Alpha Tau Medical (DRTS) Change in Cash (2021 - 2022)

Alpha Tau Medical's (DRTS) quarterly Change in Cash came in at -$86.5 million in Q2 2022, down 215.31% quarter-over-quarter from $75.1 million in Q1 2022.

Alpha Tau Medical (DRTS) Change in Cash (2021 - 2022) Analysis & Trends

Alpha Tau Medical has disclosed Change in Cash across 2 years of filings, most recently posting -$86.5 million for Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - 2.44 Mn
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 623.00 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -2.44 Mn
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 417.10 Mn
9 Abivax 95.45 Bn 95.45 Bn - -45.97 Mn
10 Alpha Tau Medical 2,384.20 -76.42 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2022 -86.55 Mn
Mar 31, 2022 75.05 Mn
Mar 31, 2021 -4.30 Mn